van der Graaf Y - Search Results

1

Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited.

Dorresteijn JA, van der Graaf Y, Spiering W, Grobbee DE, Bots ML, Visseren FL; Secondary Manifestations of Arterial Disease Study Group. Dorresteijn JA, et al. Among authors: van der graaf y. Hypertension. 2012 Jan;59(1):14-21. doi: 10.1161/HYPERTENSIONAHA.111.179143. Epub 2011 Nov 7. Hypertension. 2012. PMID: 22068865

2

Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.

Westerink J, van der Graaf Y, Faber DR, Spiering W, Visseren FL; SMART study group. Westerink J, et al. Among authors: van der graaf y. Eur J Prev Cardiol. 2012 Aug;19(4):864-73. doi: 10.1177/1741826711416045. Epub 2011 Jul 1. Eur J Prev Cardiol. 2012. PMID: 21724680

3

Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects.

Dorresteijn JA, Visseren FL, Ridker PM, Paynter NP, Wassink AM, Buring JE, van der Graaf Y, Cook NR. Dorresteijn JA, et al. Among authors: van der graaf y. Eur Heart J. 2011 Dec;32(23):2962-9. doi: 10.1093/eurheartj/ehr423. Epub 2011 Nov 16. Eur Heart J. 2011. PMID: 22090661 Free PMC article. Clinical Trial.

4

The prevalence of obesity-related hypertension and risk for new vascular events in patients with vascular diseases.

Vernooij JW, van der Graaf Y, Visseren FL, Spiering W; SMART study group. Vernooij JW, et al. Among authors: van der graaf y. Obesity (Silver Spring). 2012 Oct;20(10):2118-23. doi: 10.1038/oby.2012.76. Epub 2012 Mar 26. Obesity (Silver Spring). 2012. PMID: 22517513 Free article.

5

Relation between adiposity and hypertension persists after onset of clinically manifest arterial disease.

Dorresteijn JA, Spiering W, Van Der Graaf Y, Visseren FL; SMART Study Group. Dorresteijn JA, et al. Among authors: van der graaf y. J Hypertens. 2012 Dec;30(12):2331-7. doi: 10.1097/HJH.0b013e328357f18a. J Hypertens. 2012. PMID: 23041751

6

Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease.

Vernooij JW, van der Graaf Y, Nathoe HM, Bemelmans RH, Visseren FL, Spiering W. Vernooij JW, et al. Among authors: van der graaf y. J Hypertens. 2013 Mar;31(3):492-99; discussion 499-500. doi: 10.1097/HJH.0b013e32835cd3cd. J Hypertens. 2013. PMID: 23303394

7

The risk of resting heart rate on vascular events and mortality in vascular patients.

Bemelmans RH, van der Graaf Y, Nathoe HM, Wassink AM, Vernooij JW, Spiering W, Visseren FL; SMARTStudy Group. Bemelmans RH, et al. Among authors: van der graaf y. Int J Cardiol. 2013 Sep 30;168(2):1410-5. doi: 10.1016/j.ijcard.2012.12.043. Epub 2013 Jan 8. Int J Cardiol. 2013. PMID: 23305859

8

Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.

van der Leeuw J, Visseren FL, Woodward M, Zoungas S, Kengne AP, van der Graaf Y, Glasziou P, Hamet P, MacMahon S, Poulter N, Grobbee DE, Chalmers J. van der Leeuw J, et al. Among authors: van der graaf y. Hypertension. 2015 Jan;65(1):115-21. doi: 10.1161/HYPERTENSIONAHA.114.04421. Epub 2014 Oct 13. Hypertension. 2015. PMID: 25312436 Clinical Trial.

9

SPRINT trial: It's not just the blood pressure!

Berkelmans GF, Visseren FL, Jaspers NE, Spiering W, van der Graaf Y, Dorresteijn JA. Berkelmans GF, et al. Among authors: van der graaf y. Eur J Prev Cardiol. 2017 Sep;24(14):1482-1484. doi: 10.1177/2047487317723213. Epub 2017 Jul 27. Eur J Prev Cardiol. 2017. PMID: 28749177 Clinical Trial.

10

Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.

van Kleef MEAM, Visseren FLJ, Vernooij JWP, Nathoe HM, Cramer MM, Bemelmans RHH, van der Graaf Y, Spiering W; SMART-study group. van Kleef MEAM, et al. Among authors: van der graaf y. J Hypertens. 2018 Sep;36(9):1865-1873. doi: 10.1097/HJH.0000000000001785. J Hypertens. 2018. PMID: 29878973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

641 results

Search Page